NCT07206615View on ClinicalTrials.gov

Spot Ex PMCF 01 Study

Enrolling by invitationOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Presence of Spot Ex Endoscopic Marker
Interventions
OTHER

Endoscopic marker

Study to confirm the safety and performance of the Laborie Spot Ex Endoscopic Marker in accordance with the approved labelling/instructions for use (IFU).

Trial Locations (1)

46202

IU Health University Hospital, Indianapolis

Sponsors
All Listed Sponsors
lead

Laborie Medical Technologies Inc.

INDUSTRY

NCT07206615 - Spot Ex PMCF 01 Study | Biotech Hunter | Biotech Hunter